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We examined the relation between gallstones, cholecystectomy, and the development of pancreatic cancer in the Nurses’
Health Study and the Health Professionals Follow-up Study. Among 104856 women and 48928 men without cancer at
baseline, we documented 349 cases of pancreatic cancer during up to 16 years of follow-up. Participants were classiﬁed
according to a history of gallstones or cholecystectomy. The age-adjusted relative risk of pancreatic cancer following
cholecystectomy or diagnosis of gallstones was 1.31 (95% CI, 0.93–1.83). However, adjustment for other pancreatic cancer
risk factors attenuated the association (RR=1.11, 95% CI, 0.78–1.56); this risk did not increase with increasing time following
cholecystectomy or gallstones. Gallstones or cholecystectomy do not appear to be signiﬁcant risk factors for pancreatic cancer.
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Pancreatic cancer is the ﬁfth leading cause of cancer-related
mortality in the US (Greenlee et al, 2001). New environmental
risk factors have consistently been linked to the risk of pancrea-
tic cancer. Animal models suggest an important role for
cytokines in experimental pancreatic carcinogenesis (Watanapa
and Williamson, 1993). Cholecystokinin (CCK) has been shown
to stimulate both gallbladder contraction and pancreatic enzyme
secretion (Marx et al, 1987; Smith et al, 1990) and to have a
trophic effect on pancreatic acinar cells (Rivard et al, 1991).
The presumed increased release of CCK following cholecystect-
omy (Hyvarinen and Partanen, 1987) might contribute to an
increased risk for pancreatic cancer risk following gallbladder
removal. In addition, cholecystectomy may suppress the normal
inhibitory effect of CCK on the Sphincter of Oddi (Luman et
al, 1997). The presence of gallstones, on the other hand, appears
to be associated with chronic pancreatitis (Hardt et al, 2001),
but whether chronic pancreatitis predisposes to pancreas cancer
remains controversial (Lowenfels et al, 1993; Ekbom et al,
1994). Some of the earlier studies reported relative risks of
pancreatic cancer of 1.2–2.0 among individuals who had under-
gone a cholecystectomy previously (Haines et al, 1982; Shibata et
al, 1994; Ekbom et al, 1996; Chow et al, 1999; Gullo, 1999;
Silverman et al, 1999; Coughlin et al, 2000); however, the
strength of the association remains uncertain because of the
retrospective design of most analyses and the reliance on next-
of-kin respondents. Prospective studies can overcome these
limitations. We examined the relation between cholecystectomy
or gallstones and pancreatic cancer risk in two large cohorts,
the Nurses’ Health Study (NHS) and the Health Professionals
Follow-up Study (HPFS).
MATERIALS AND METHODS
Study cohorts
The Nurses’ Health Study (NHS) enrolled 121700 female, regis-
tered nurses aged 30–55 years in 1976, and information on their
health status, medical history, and known and suspected risk
factors for cancer and coronary heart disease was gathered
through mailed questionnaires. The Health Professionals
Follow-up Study (HPFS) began in 1986, when 51529 American
male dentists, optometrists, osteopaths, pharmacists, podiatrists,
and veterinarians aged 40–75 years completed a mailed ques-
tionnaire on health-related questions similar to those in NHS.
Follow-up questionnaires were sent biennially to participants in
both cohorts.
Ascertainment of cholecystectomy or gallstone diagnosis
In 1982, the study participants of the NHS were asked about their
history of cholecystectomy and the year of surgery, with informa-
tion updated biennially. History of gallstones that were not
removed was also assessed on the 1982 questionnaire but was
updated only through 1986. In the HPFS, participants were asked
about their history of cholecystectomy or gallstones at baseline,
and both questions were updated with all subsequent question-
naires.
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We included conﬁrmed pancreatic cancers diagnosed between the
return of the 1982 questionnaire and June 1, 1998, for the NHS
and between the return of the 1986 questionnaire and January 1,
1998, for the HPFS. With permission from study participants, we
conﬁrmed pancreatic cancer through physicians’ review of their
medical records. If permission was denied, we attempted to
conﬁrm the self-reported cancer with an additional letter or phone
call. We also searched the National Death Index to identify deaths
among the nonrespondents to each 2-year questionnaire. The
computerised National Death Index is a highly sensitive method
for identifying death in this cohort (Stampfer et al, 1984). For all
deaths attributable to pancreatic cancer, we requested permission
from family members (subject to state regulation) to review the
medical records. Pancreatic cancer was considered the cause of
death if the medical records or autopsy report conﬁrmed fatal
pancreatic cancer or when pancreatic cancer was listed as the
underlying cause of death without another, more plausible cause.
In this analysis, we included 170 cases of pancreatic cancer in
the women and 127 in the men.
Statistical analysis
We excluded participants who did not answer the baseline ques-
tionnaire on gallstones and cholecystectomy (1982 in the NHS;
1986 in the HPFS) and all participants who reported a history of
cancer (with the exception of non-melanoma skin cancer). Since
the diagnosis of gallstones or the need for cholecystectomy might
have been triggered by early symptoms associated with pancreatic
cancer, we also excluded the ﬁrst 2 years of follow-up for all study
participants after their ﬁrst report of either cholelithiasis or chole-
cystectomy. Therefore, for NHS participants who did not report
gallstones or cholecystectomy between 1984 and 1986, we initiated
follow-up with the date of return of the baseline 1982 question-
naire, whereas, for women who reported gallstones or
cholecystectomy between 1984 and 1986, follow up began in
1988. In the HPFS, however, the baseline 1986 questionnaire
assessed history of gallstones and cholecystectomy in timeframes
that were larger than a 2-year interval. There, for all HPFS partici-
pants, we initiated follow-up with the date of return of the 1988 to
ensure that persons reporting a history of either gallstones or a
cholecystectomy were excluded from the succeeding 2 years of
analysis only. In both cohorts, we computed person years of
follow-up to the date of diagnosis of pancreatic cancer, death from
any cause, or to the end of the study period (June 1, 1998, for
women, and February 1, 1998 for men) whichever occurred ﬁrst.
After these exclusions, 104856 women and 48928 men were
eligible for follow-up, and 1405681 person years were accrued in
the NHS and 441387 in the HPFS.
The primary analysis used incidence rates with person-years of
follow-up in the denominator. We used relative risk (RR) as the
measure of association; RR was deﬁned as the incidence rate of
pancreatic cancer among participants with a history of gallstones
or a cholecystectomy divided by the incidence rate among partici-
pants without such a history. In the NHS, person time with
gallstones history from 1986 on was based on the cumulative
history of gallstones up to 1986. For each cohort, we used Cox
proportional hazards models to adjust for other potential risk
factors for pancreatic cancer. Although rapid weight loss in obese
patients constitutes a risk factor for gallstones (Yang et al, 1992),
pancreatic cancer is also frequently associated with profound
weight loss. Therefore, we did not adjust for weight change or most
recent body mass index but used baseline body mass index (1976
for the NHS, 1986 for the HPFS), which appeared to be the most
important weight risk factor for pancreatic cancer in these cohorts
(Michaud et al, 2001). We used a random-effects model for the log
of the RR (DerSimonian and Laird, 1986) to pool the data from
the two cohorts.
RESULTS
A total of 206 women and 143 men were diagnosed with pancreatic
cancer during 2162077 person-years of follow-up. Of these 349
persons, 333 (96%) died of the disease. At baseline, 9.2% of the
women (16.4% by 1996) and 3.7% of the men (7.1% by 1996)
reported gallstones or a history of cholecystectomy. Characteristics
of the study population are described in Table 1.
In our primary analysis we excluded participants who reported a
history of cholecystectomy or gallstones from the proceeding 2
years of analysis, which left 170 women and 127 men with a diag-
nosis of pancreatic cancer. Of these, women with a history of
gallstones or a cholecystectomy experienced a modest elevation in
risk for pancreatic cancer (age-adjusted RR=1.47, 95% CI, 1.00–
2.16), whereas men with such a history did not experience an
obvious increase in risk (Table 2). Among men and women
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Table 1 Age and age-standardized
a characteristics by exposure status (gallstones and/or cholecystectomy) among
women in the NHS and men in the HPFS
Gallstones and/or cholecystectomy
NHS HPFS
Characteristics
b Yes No Yes No
Number of individuals 9696 95 160 1799 47 129
Age in years, mean (s.d.) 50.9 (6.9) 48.8 (7.2) 60.8 (9.1) 54.2 (9.7)
Height in inches, mean (s.d.) 64.4 (3.4) 64.4 (3.3) 69.8 (3.0) 70.1 (2.9)
Baseline body mass index 530 (%) 20.2 6.8 16.5 7.8
History of diabetes (%) 6.5 2.6 5.4 3.1
Current smokers (%) 30.7 27.7 11.4 9.6
Average pack–years ever smoked (current or past), mean (s.d.) 5.4 (8.7) 4.7 (7.9) 13.0 (73.9) 5.0 (35.1)
Physical activity level in MET – hours/week
c (s.d.) 12.2 (17.5) 14.3 (21.4) 15.9 (21.2) 20.3 (26.3)
Current PMH
d use 525 years (%) 6.8 4.8 N.A. N.A.
Nulliparous (%) 5.3 6.8 N.A. N.A.
Parity 55 children (%) 16.5 14.1 N.A. N.A.
aAge-standardized, using ﬁve 5-years categories for the NHS (549, 50–54, 55–59, 60–64 and 65+ years) and eight 5-years cate-
gories for the HPFS (549, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, 80+ years) of age as of the 2-year period when
participants ﬁrst entered follow-up.
bBaseline: 1982 for NHS, 1986 for HPFS.
cMET–h/week, sum of the average time/week spent
in each activity by its typical energy-expenditure requirements expressed in metabolic equivalents (METs), MET, caloric need per kilo-
gram of body weight per hour activity, divided by the caloric need per kg per h at rest.
dPMH, postmenopausal hormones.
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However, after adjusting for other factors, including body mass
index and physical activity, the RR was 1.11 (95% CI, 0.78–
1.56). Adjustment for postmenopausal hormone use and parity
among women did not substantially alter our estimates (data not
shown).
Multivariate RRs in the analyses that included all 349 diagnosed
pancreatic cancer case subjects were not substantially different from
the primary analyses for women (RR=1.16, 95% CI, 0.81–1.66),
men (RR=0.96, 95% CI, 0.52–1.75), or women and men combined
(RR=1.10, 95% CI, 0.81–1.50).
We examined the relation between time since cholecystectomy
and risk of pancreatic cancer. Among individuals with a cholecys-
tectomy 10 or fewer years in the past, the multivariate RR for
pancreatic cancer was 1.12 (95% CI, 0.66–1.89), whereas for more
than 10 years in the past, the RR was 1.13 (95% CI, 0.76–1.68).
For cholecystectomy more than 20 years in the past, the RR was
0.88 (95% CI, 0.49–1.59). These ﬁndings were not materially
different when we examined time interval since cholecystectomy
or a diagnosis of gallstones; for individuals with a history of either
cholecystectomy or gallstones more than 10 years previously, the
RR for pancreatic cancer was 1.16 (95% CI, 0.79–1.70).
DISCUSSION
In two prospective cohorts of women and men, risk for pancreatic
cancer following diagnosis of gallstones or cholecystectomy was
modestly but not signiﬁcantly increased. This risk was attenuated
substantially after adjustment for potential confounders, including
body mass index and physical activity. Furthermore, the risk did
not increase in the decades following either cholecystectomy or
diagnosis of gallstones.
The prospective nature of our studies precluded recall bias and
the need of next-of-kin respondents. Moreover, to avoid misclassi-
ﬁcation of exposure, we updated reports of cholecystectomy and
gallstones biennially. Because identiﬁcation of deaths is highly
accurate in these cohorts (Stampfer et al, 1984), differential
follow-up is unlikely. Nonetheless, case number may have compro-
mised the ability to explore further details in these cohorts. Based
on the available statistical power, we cannot completely exclude an
effect for cholecystectomy or cholelithiasis, although in both
cohorts the effect appears to be consistently small. It is possible
that gallstones and pancreatic cancer have similar etiologic factors
(e.g. hyperinsulinemia), which may account for an association
between the two. Controlling for physical activity and BMI, a
strong determinant of hyperinsulinaemia, reduced the modest asso-
ciation between cholecystectomy and pancreatic cancer.
Previous studies have investigated a potential association
between gallstones or cholecystectomy and risk of pancreatic
cancer. Results from case-control studies have been conﬂicting
(Haines et al, 1982; Shibata et al, 1994; Ekbom et al, 1996; Cough-
lin et al, 2000), although some indicate a 30–70% increased risk of
pancreatic cancer in association with gallstones or after a cholecys-
tectomy (Chow et al, 1999; Gullo, 1999; Silverman et al, 1999;
Silverman, 2001). In the largest case-control study, Silverman
(2001) observed a RR of 1.7 (95%CI, 1.0–1.3). One prospective
study found an increased RR for pancreatic cancer of 1.99 (95%
CI, 1.08–3.68) associated with cholecystectomy after adjustment
for sex, age, and cigarette smoking (Shibata et al, 1994). However,
that study did not adjust for potential confounders such as obesity
and was limited by a small number of cases. The only other cohort
study observed a slightly elevated risk for pancreatic cancer in men
with a history of gallstones (RR 1.2, 95% CI, 1.0–1.5), but their
ability to control for potential confounding factors in this large
cohort was compromised by incomplete follow-up (Coughlin et
al, 2000). Few studies have examined the time interval between
cholecystectomy and incidence of pancreatic cancer. Silverman
(2001) found a 70% excess risk of pancreatic cancer 20 or more
years after a cholecystectomy. In contrast, Hyvarinen and Partanen
found a statistically signiﬁcant increased risk of pancreatic cancer
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Table 2 Adjusted relative risks (RRs) of pancreatic cancer by exposure to gallstones, cholecystectomy
(CHE), and both combined (either/or) among 104 856 women in the NHS and 49 063 men in the HPFS,
with prospective follow-up 1982–1998 (NHS) and 1988–1998 (HPFS) (total cases of pancreatic cancer,
297). Exclusion of the ﬁrst 2 years of follow-up if the exposure was within 2 years of its being reported
Neither cholecystectomy Cholecystectomy
nor gallstones Gallstones Cholecystectomy or gallstones
NHS women
No. of cases 138 14 29 32
Person–years 1 255 822 72 493 129 750 149 859
Age-adjusted RR (95% CI) 1.0 1.31 (0.75–2.27) 1.54 (1.03–2.29) 1.47 (1.00–2.16)
Multivariate RR (95% CI)
a 1.0 1.21 (0.70–2.11) 1.42 (0.95–2.14) 1.34 (0.91–1.99)
Multivariate RR (95% CI)
b 1.0 1.09 (0.62–1.91) 1.27 (0.84–1.92) 1.19 (0.80–1.77)
HPFS men
No. of cases 118 7 8 9
Person–years 419 533 16 230 16 177 21 854
Age-adjusted RR (95% CI) 1.0 0.99 (0.46–2.14) 1.19 (0.58–2.43) 0.97 (0.49–1.91)
Multivariate RR (95% CI)
a 1.0 0.92 (0.42–2.00) 1.18 (0.57–2.45) 0.95 (0.481.89)
Multivariate RR (95% CI)
b 1.0 0.87 (0.40–1.90) 1.12 (0.54–2.33) 0.89 (0.45–1.78)
Combined cohorts
No. of cases 256 21 37 41
Person–years 1 675 355 88 723 145 927 171 713
Age-adjusted RR (95% CI) 1.0 1.17 (0.751.83) 1.45 (1.02–2.07) 1.31 (0.93–1.83)
Multivariate RR (95% CI)
a 1.0 1.10 (0.70–1.73) 1.36 (0.95–1.94) 1.23 (0.88–1.74)
Multivariate RR (95% CI)
b 1.0 1.00 (0.64–1.59) 1.23 (0.86–1.77) 1.11 (0.78–1.56)
aMultivariate risks from proportional hazards models are adjusted for age in months, follow-up cycle, history of diabetes
(yes/no), and smoking status in six categories (never, quit 515 years ago, quit 515 years ago, and smoked 425 pack–
years in past 15 years, quit 515 years ago and smoked 425 pack–years in past 15 years, current smoker with 425
pack–years in past 15 years, current smoker with 425 pack–years in past 15 years).
bMultivariate risks from propor-
tional hazards models are adjusted for age in months, follow-up cycle, history of diabetes, smoking status, nonvigorous
physical activity METs/week, in quintiles, cohort baseline (NHS: 1976, HPFS: 1986), and baseline bodymass index (1976
for the NHS, 1986 for the HPFS) in ﬁve categories (521, 21–22.9, 23–24.9, 25–28.9, 29–40+ for the NHS and
522.9, 23–24.9, 25–26.9, 27–29.9, 30+ for the HPFS).
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(Hyvarinen and Partanen, 1987). Moreover, Ekbom et al (1996)
found no increase in risk with increased duration after cholecys-
tectomy.
Although the age-adjusted ﬁndings in our two cohorts are some-
what more consistent with previous positive results, multivariate
adjustment suggests considerable confounding in this relation.
In summary, our ﬁndings do not support a strong relation
between gallstones or prior cholecystectomy and pancreatic cancer
risk. The effect of gallstones and cholecystectomy on pancreatic
cancer risk appears small and residual confounding by risk factors
for both cholecystectomy and pancreatic cancer may have
explained the results in previous studies.
ACKNOWLEDGEMENTS
This research was supported by National Cancer Institute Grants
CA/ES62984 and CA87969, as well as CA 40356, CA 55075, and
CA 86102. Dr Schernhammer was supported in part by a Research
Grant in Cancer Prevention from the Austrian Federal Ministry of
Education, Science and Culture. We are indebted to the partici-
pants of the Nurses’ Health Study for their continuing
outstanding dedication to the study and to Karen Corsano for
technical assistance.
REFERENCES
Chow WH, Johansen C, Gridley G, Mellemkjaer L, Olsen J, Fraumeni JFJ
(1999) Gallstones, cholecystectomy and risk of cancers of the liver, biliary
tract and pancreas. Br J Cancer 79: 640–644
Coughlin SS, Calle EE, Patel AV, Thun MJ (2000) Predictors of pancreatic
mortality among a large cohort of United States adults. Cancer Causes
Control 11: 915–923
DerSimonian R, Laird N (1986) Meta-analysis in Clinical Trials. Controlled
Clin Trials 7: 177–188
Ekbom A, McLaughlin JK, Karlsson BM, Nyren O, Gridley G, Adami HO,
Fraumeni JFJ (1994) Pancreatitis and pancreatic cancer: a population-
based study. J Natl Cancer Inst 86: 625–627
Ekbom A, Yuen J, Karlsson BM, McLaughlin JK, Adami HO (1996) Risk of
pancreatic and periampullar cancer following cholecystectomy: a popula-
tion-based cohort study. Dig Dis Sci 41: 387–391
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer Statistics,.
(2001.) CA Cancer J Clin 51: 15–36
Gullo L (1999) Risk of pancreatic and periampullary cancer following chole-
cystectomy. Ann Oncol 10: 127–128
Haines AP, Moss AR, Whittemore A, Quivey J (1982) A case-control study of
pancreatic carcinoma. Cancer Res Clin Oncol 103: 93–97
Hardt PD, Bretz L, Krauss A, Schnell-Kretschmer H, Wusten O, Nalop J,
Zekorn T, Klor HU (2001) Pathological pancreatic exocrine function
and duct morphology in patients with cholelithiasis. Dig Dis Sci 46:
536–539
Hyvarinen H, Partanen S (1987) Association of cholecystectomy with abdom-
inal cancers. Hepatogastroenterology 34: 280–284
Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG,
Andersen JR, Dimagno EP, Andren-Sandberg A, Domellof L (1993)
Pancreatitis and the risk of pancreatic cancer. International Pancreatits
Study Group. N Engl J Med 328: 1433–1437
Luman W, Williams AJ, Pryde A, Smith GD, Nixon SJ, Heading RC, Palmer
KR (1997) Inﬂuence of cholecystectomy on sphincter of Oddi motility. Gut
41: 371–374
Marx M, Gomez G, Lonovics J, Thompson JC (1987) Cholecystokinin. In
Gastrointestinal Endocrinology Thompson JC, Greeley Jr GH, Rayford PL,
Townsend Jr CM (eds) pp 213–222 New York: McGraw-Hill
Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs
CS (2001) Physical activity, obesity, height, and the risk of pancreatic
cancer. JAMA 286: 921–929
Rivard N, Guan D, Maouyo D, Grondin G, Berube FL, Morisset J (1991)
Endogenous cholecystokinin release responsible for pancreatic growth
observed following pancreatic juice diversion. Endocrinology 129: 2867–
2874
Shibata A, Mack TM, Paganini-Hill A, Ross RK, Henderson BE (1994) A
prospective study of pancreatic cancer in the elderly. Int J Cancer 58:
46–49
Silverman DT (2001) Risk factors for pancreatic cancer: a case-control study
based on direct interviews. Teratog Carcinog Mutagen 21: 7–25
Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson
GM, Schwartz AG, Brown LM, Greenberg RS, Schoenberg JB, Pottern LM,
Hoover RN, Fraumeni JFJ (1999) Diabetes mellitus, other medical condi-
tions and familial history of cancer as risk factors for pancreatic cancer. Br
J Cancer 80: 1830–1837
Smith JP, Salomon TE, Bagheri S, Kramer S (1990) Cholecystokinin stimu-
lates growth of human pancreatic adenocarcinoma. Dig Dis Sci 35:
1377–1384
Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B,
Hennekens CH (1984) Test of the national death index. Am J Epidemiol
119: 837–839
Watanapa P, Williamson RCN (1993) Experimental pancreatic hyperplasia
and neoplasia: effects of dietary and surgical manipulation. Br J Cancer
67: 877–884
Yang H, Petersen GM, Roth MP, Schoenﬁeld LJ, Marks JW (1992) Risk
factors for gallstone formation during rapid weight loss. Dig Dis Sci 37:
912–918
E
p
i
d
e
m
i
o
l
o
g
y
Gallstones cholecystectomy, and risk of pancreatic cancer
ES Schernhammer et al
1084
British Journal of Cancer (2002) 86(7), 1081–1084 ã 2002 Cancer Research UK